Deerfield operates as a leading investment management firm. The company is committed to advancing healthcare through investment, philanthropy and information. Today, Deerfield had announced funding of a credit facility for Imris Inc.
Imris Inc. is a global leader in providing image guided therapy solutions. The Canada based company provides clients with a fully integrated therapy environment which was designed to provide timely information to clinicians. This would be a great help during surgical or interventional procedures. Deerfield funded a USD25 million of financing facility for Imris.
Imris had generated more than USD50 million in revenues for each of the last four years. The company had been looking to expand into intraoperative CT, radiation oncology and robotic neuro-surgery segments.
Deerfield had received a note with a 9% coupon with warrants that could represent around 10% of the company's shares upon exercise. Deerfield had also collected a USD500000 facility fee for the financing transaction.
Join the Conversation